Indraprastha Medical Crecimiento futuro

Future controles de criterios 0/6

Actualmente no disponemos de suficiente cobertura de analistas para prever el crecimiento y los ingresos de Indraprastha Medical.

Información clave

n/a

Tasa de crecimiento de los beneficios

n/a

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Healthcare	27.4%
Tasa de crecimiento de los ingresos	n/a
Rentabilidad financiera futura	n/a
Cobertura de analistas	None
Última actualización	n/a

Actualizaciones recientes sobre el crecimiento futuro

No hay actualizaciones

Recent updates

Calculating The Fair Value Of Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)

Oct 14

We Take A Look At Why Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) CEO Compensation Is Well Earned

Sep 18

Indraprastha Medical's (NSE:INDRAMEDCO) Shareholders Will Receive A Bigger Dividend Than Last Year

Aug 30

Indraprastha Medical's (NSE:INDRAMEDCO) Shareholders Will Receive A Bigger Dividend Than Last Year

Aug 11

Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO) Soars 34% But It's A Story Of Risk Vs Reward

Aug 08

Investors Should Be Encouraged By Indraprastha Medical's (NSE:INDRAMEDCO) Returns On Capital

Jun 12

Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO) Shares Fly 42% But Investors Aren't Buying For Growth

Apr 06

Why Investors Shouldn't Be Surprised By Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) Low P/E

Feb 01

Why The 29% Return On Capital At Indraprastha Medical (NSE:INDRAMEDCO) Should Have Your Attention

Nov 03

We Think Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) CEO Compensation Looks Fair

Sep 15

Indraprastha Medical's (NSE:INDRAMEDCO) Dividend Will Be Increased To ₹3.00

Sep 10

Indraprastha Medical's (NSE:INDRAMEDCO) Upcoming Dividend Will Be Larger Than Last Year's

Aug 27

Indraprastha Medical (NSE:INDRAMEDCO) Is Paying Out A Larger Dividend Than Last Year

Aug 08

Why We Like The Returns At Indraprastha Medical (NSE:INDRAMEDCO)

Jul 31

Indraprastha Medical (NSE:INDRAMEDCO) Is Very Good At Capital Allocation

Jan 21

We Think Indraprastha Medical's (NSE:INDRAMEDCO) Profit Is Only A Baseline For What They Can Achieve

Nov 12

Estimating The Intrinsic Value Of Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)

Nov 02

Why We Like The Returns At Indraprastha Medical (NSE:INDRAMEDCO)

May 12

Estimating The Intrinsic Value Of Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)

Jun 10

Introducing Indraprastha Medical (NSE:INDRAMEDCO), A Stock That Climbed 24% In The Last Year

Feb 21

En esta sección solemos presentar previsiones de crecimiento de ingresos y beneficios basadas en las estimaciones por consenso de analistas profesionales para ayudar a los inversores a comprender la capacidad de la empresa para generar beneficios. Pero como Indraprastha Medical no ha proporcionado suficientes datos anteriores y no dispone de previsiones de analistas, sus beneficios futuros no pueden calcularse de forma fiable extrapolando datos anteriores o utilizando las previsiones de los analistas.

Es una situación poco común, ya que el 97% de las empresas disponibles en SimplyWall St sí disponen de datos financieros anteriores.

Previsiones de crecimiento de beneficios e ingresos

NSEI:INDRAMEDCO - Estimaciones futuras de los analistas y datos financieros pasados (INR Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
9/30/2024	13,189	1,478	1,079	1,620	N/A
6/30/2024	12,861	1,382	N/A	N/A	N/A
3/31/2024	12,447	1,240	1,308	2,002	N/A
12/31/2023	12,040	1,126	N/A	N/A	N/A
9/30/2023	11,745	1,041	447	1,084	N/A
6/30/2023	11,419	964	N/A	N/A	N/A
3/31/2023	10,987	862	999	1,445	N/A
12/31/2022	10,411	815	N/A	N/A	N/A
9/30/2022	10,000	765	1,133	1,432	N/A
6/30/2022	9,486	635	N/A	N/A	N/A
3/31/2022	8,882	586	648	943	N/A
12/31/2021	8,705	585	N/A	N/A	N/A
9/30/2021	8,139	546	726	974	N/A
6/30/2021	7,221	430	N/A	N/A	N/A
3/31/2021	6,134	23	59	268	N/A
12/31/2020	6,158	-63	N/A	N/A	N/A
9/30/2020	6,462	-76	417	632	N/A
6/30/2020	7,213	99	N/A	N/A	N/A
3/31/2020	8,308	436	455	865	N/A
12/31/2019	8,307	443	N/A	N/A	N/A
9/30/2019	8,185	407	N/A	N/A	N/A
6/30/2019	8,025	305	N/A	N/A	N/A
3/31/2019	7,882	284	581	752	N/A
12/31/2018	7,734	269	N/A	N/A	N/A
9/30/2018	7,610	253	N/A	N/A	N/A
6/30/2018	7,527	228	N/A	N/A	N/A
3/31/2018	7,527	211	N/A	477	N/A
12/31/2017	7,471	202	N/A	N/A	N/A
9/30/2017	7,537	207	N/A	N/A	N/A
6/30/2017	7,564	228	N/A	N/A	N/A
3/31/2017	7,657	262	N/A	276	N/A
12/31/2016	7,660	304	N/A	N/A	N/A
9/30/2016	7,635	283	N/A	N/A	N/A
6/30/2016	7,640	296	N/A	N/A	N/A
3/31/2016	7,554	244	N/A	623	N/A
12/31/2015	7,472	303	N/A	N/A	N/A
9/30/2015	7,340	323	N/A	N/A	N/A
6/30/2015	7,226	321	N/A	N/A	N/A
3/31/2015	7,145	325	N/A	643	N/A
12/31/2014	7,016	321	N/A	N/A	N/A
9/30/2014	6,949	331	N/A	N/A	N/A
6/30/2014	6,897	342	N/A	N/A	N/A
3/31/2014	6,776	354	N/A	581	N/A
12/31/2013	6,663	347	N/A	N/A	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Datos insuficientes para determinar si el crecimiento previsto de los beneficios de INDRAMEDCO es superior a la tasa de ahorro (6.7%).

Beneficios vs. Mercado: Datos insuficientes para determinar si se prevé que los beneficios de INDRAMEDCO crezcan más rápidamente que el mercado Indian

Beneficios de alto crecimiento: Datos insuficientes para determinar si se espera que los beneficios de INDRAMEDCO crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: No hay datos suficientes para determinar si se prevé que los ingresos de INDRAMEDCO crezcan más rápidamente que el mercado de Indian.

Ingresos de alto crecimiento: No hay datos suficientes para determinar si se prevé que los ingresos de INDRAMEDCO crezcan a un ritmo superior a 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de INDRAMEDCO se prevé que sea elevada dentro de 3 años.

Indraprastha Medical Crecimiento futuro

Future controles de criterios 0/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Second quarter 2025 earnings released: EPS: ₹4.63 (vs ₹3.58 in 2Q 2024)

Calculating The Fair Value Of Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)

Indraprastha Medical Corporation Limited Approves the Cash Dividend for the Financial Year Ended March 31, 2024

We Take A Look At Why Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) CEO Compensation Is Well Earned

Investor sentiment improves as stock rises 19%

Now 22% overvalued after recent price rise

Upcoming dividend of ₹4.50 per share

Indraprastha Medical's (NSE:INDRAMEDCO) Shareholders Will Receive A Bigger Dividend Than Last Year

Investor sentiment improves as stock rises 16%

Indraprastha Medical's (NSE:INDRAMEDCO) Shareholders Will Receive A Bigger Dividend Than Last Year

Dividend increased to ₹4.50

Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO) Soars 34% But It's A Story Of Risk Vs Reward

Indraprastha Medical Corporation Limited, Annual General Meeting, Sep 24, 2024

First quarter 2025 earnings released: EPS: ₹4.88 (vs ₹3.33 in 1Q 2024)

Indraprastha Medical Corporation Limited to Report Q1, 2025 Results on Aug 05, 2024

Investors Should Be Encouraged By Indraprastha Medical's (NSE:INDRAMEDCO) Returns On Capital

New major risk - Share price stability

Full year 2024 earnings released: EPS: ₹13.52 (vs ₹9.40 in FY 2023)

Indraprastha Medical Corporation Limited Recommends Dividend for the Financial Year 2024

Indraprastha Medical Corporation Limited to Report Q4, 2024 Results on May 17, 2024

New minor risk - Share price stability

Investor sentiment improves as stock rises 20%

Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO) Shares Fly 42% But Investors Aren't Buying For Growth

Investor sentiment improves as stock rises 21%

Now 22% overvalued

Third quarter 2024 earnings released: EPS: ₹3.21 (vs ₹2.28 in 3Q 2023)

Why Investors Shouldn't Be Surprised By Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) Low P/E

Indraprastha Medical Corporation Limited to Report Q3, 2024 Results on Feb 06, 2024

Indraprastha Medical Corporation Limited Announces Cessation of Jasmine Shah as Non-Executive Director & Chairman

Investor sentiment improves as stock rises 19%

Second quarter 2024 earnings released: EPS: ₹3.58 (vs ₹2.74 in 2Q 2023)

Why The 29% Return On Capital At Indraprastha Medical (NSE:INDRAMEDCO) Should Have Your Attention

Indraprastha Medical Corporation Limited to Report First Half, 2024 Results on Nov 03, 2023

Now 21% undervalued

We Think Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) CEO Compensation Looks Fair

Indraprastha Medical's (NSE:INDRAMEDCO) Dividend Will Be Increased To ₹3.00

Upcoming dividend of ₹3.00 per share at 1.8% yield

Now 22% undervalued

Indraprastha Medical's (NSE:INDRAMEDCO) Upcoming Dividend Will Be Larger Than Last Year's

Investor sentiment improves as stock rises 15%

Indraprastha Medical (NSE:INDRAMEDCO) Is Paying Out A Larger Dividend Than Last Year

First quarter 2024 earnings released: EPS: ₹3.33 (vs ₹2.21 in 1Q 2023)

Indraprastha Medical Corporation Limited, Annual General Meeting, Sep 21, 2023

Why We Like The Returns At Indraprastha Medical (NSE:INDRAMEDCO)

Indraprastha Medical Corporation Limited to Report Q1, 2024 Results on Aug 04, 2023

Investor sentiment improves as stock rises 16%

Indraprastha Medical Corporation Limited Recommends Dividend for the Financial Year 2022-23

Full year 2023 earnings released: EPS: ₹9.40 (vs ₹6.39 in FY 2022)

Indraprastha Medical Corporation Limited to Report Q4, 2023 Results on May 23, 2023

Third quarter 2023 earnings released: EPS: ₹2.28 (vs ₹1.74 in 3Q 2022)

Indraprastha Medical Corporation Limited to Report Q3, 2023 Results on Feb 08, 2023

Indraprastha Medical (NSE:INDRAMEDCO) Is Very Good At Capital Allocation

We Think Indraprastha Medical's (NSE:INDRAMEDCO) Profit Is Only A Baseline For What They Can Achieve

Investor sentiment improved over the past week

Second quarter 2023 earnings released: EPS: ₹2.74 (vs ₹1.32 in 2Q 2022)

Estimating The Intrinsic Value Of Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)

Indraprastha Medical Corporation Limited to Report Q2, 2023 Results on Nov 04, 2022

Indraprastha Medical Corporation Limited Approves Dividend on Equity Shares for the Financial Year Ended on 31 March, 2022

Upcoming dividend of ₹2.50 per share

Indraprastha Medical Corporation Limited Proposes Dividend for the Fiscal Year 2022

First quarter 2023 earnings released: EPS: ₹2.21 (vs ₹1.68 in 1Q 2022)

Indraprastha Medical Corporation Limited, Annual General Meeting, Sep 23, 2022

Indraprastha Medical Corporation Limited to Report Q1, 2022 Results on Aug 08, 2022

Full year 2022 earnings released: EPS: ₹6.39 (vs ₹0.25 in FY 2021)

Indraprastha Medical Corporation Limited Recommends Dividend for the Financial Year 2021-2022

Why We Like The Returns At Indraprastha Medical (NSE:INDRAMEDCO)

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Second quarter 2022 earnings released: EPS ₹1.32 (vs ₹0.05 in 2Q 2021)

First quarter 2022 earnings released: EPS ₹1.68 (vs ₹1.35 loss in 1Q 2021)

Full year 2021 earnings released: EPS ₹0.25 (vs ₹4.76 in FY 2020)

Estimating The Intrinsic Value Of Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)

Introducing Indraprastha Medical (NSE:INDRAMEDCO), A Stock That Climbed 24% In The Last Year

Third quarter 2021 earnings released: EPS ₹1.31 (vs ₹1.16 in 3Q 2020)

Indraprastha Medical Corporation Limited Announces Board Changes

Indraprastha Medical Corporation Limited to Report Q3, 2021 Results on Feb 08, 2021